Literature DB >> 22058176

Association between cold dialysis and cardiovascular survival in hemodialysis patients.

Heng-Jung Hsu1, Chiung-Hui Yen, Kuang-Hung Hsu, Chin-Chan Lee, Shu-Ju Chang, I-Wen Wu, Chiao-Yin Sun, Chia-Chi Chou, Chen-Chao Yu, Ming-Fang Hsieh, Chun-Yu Chen, Chiao-Ying Hsu, Cheng-Hao Weng, Chi-Jen Tsai, Mai-Szu Wu.   

Abstract

BACKGROUND: Higher cardiovascular mortality has been noted in patients with chronic kidney disease (CKD). CKD patients are also known to have impaired energy expenditure but the role of energy expenditure in cardiovascular disease is not yet known. Furthermore, the association between cold dialysis (CD) and clinical outcomes in hemodialysis patients is unclear.
METHODS: This was a single-center retrospective cohort study consisting of two groups: a CD group with dialyzate temperature <35.5 °C and a standard dialysis (SD) group with dialyzate temperature between 35.5 and 37 °C. The end points of the study were overall mortality, cardiac mortality and non-cardiac mortality. The study analyzed the associations between dialyzate temperature and long-term survival in CD and SD groups. Propensity score analysis was used to control for intergroup baseline differences.
RESULTS: Baseline characteristics of both groups were similar. Kaplan-Meier analysis showed that CD was significantly associated with a lower risk for overall mortality (P = 0.006) and cardiac mortality (P = 0.023) but not for non-cardiac mortality or infectious mortality. After multivariate Cox regression analysis, adjusting for propensity scores and other possible confounding factors, CD remained a significant beneficial factor for overall mortality (P = 0.030) and cardiac mortality (P = 0.034).
CONCLUSION: Our studies show that CD is significantly and independently associated with a lower risk for overall mortality and cardiac mortality.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22058176     DOI: 10.1093/ndt/gfr615

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  7 in total

Review 1.  Kt/V (and especially its modifications) remains a useful measure of hemodialysis dose.

Authors:  John T Daugirdas
Journal:  Kidney Int       Date:  2015-07-15       Impact factor: 10.612

2.  Measuring intradialytic hypotension to improve quality of care.

Authors:  John T Daugirdas
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

Review 3.  Why choose high volume online post-dilution hemodiafiltration?

Authors:  Carlo Basile; Andrew Davenport; Peter J Blankestijn
Journal:  J Nephrol       Date:  2016-09-01       Impact factor: 3.902

Review 4.  Effect of Lowering the Dialysate Temperature in Chronic Hemodialysis: A Systematic Review and Meta-Analysis.

Authors:  Reem A Mustafa; Fadi Bdair; Elie A Akl; Amit X Garg; Heather Thiessen-Philbrook; Hassan Salameh; Sood Kisra; Gihad Nesrallah; Ahmad Al-Jaishi; Parth Patel; Payal Patel; Ahmad A Mustafa; Holger J Schünemann
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-28       Impact factor: 8.237

5.  Major Outcomes With Personalized Dialysate TEMPerature (MyTEMP): Rationale and Design of a Pragmatic, Registry-Based, Cluster Randomized Controlled Trial.

Authors:  Ahmed A Al-Jaishi; Christopher W McIntyre; Jessica M Sontrop; Stephanie N Dixon; Sierra Anderson; Amit Bagga; Derek Benjamin; David Berry; Peter G Blake; Laura Chambers; Patricia C K Chan; Nicole Delbrouck; P J Devereaux; Luis F Ferreira-Divino; Richard Goluch; Laura Gregor; Jeremy M Grimshaw; Garth Hanson; Eduard Iliescu; Arsh K Jain; Charmaine E Lok; Reem A Mustafa; Bharat Nathoo; Gihad E Nesrallah; Matthew J Oliver; Sanjay Pandeya; Malvinder S Parmar; David Perkins; Justin Presseau; Eli Rabin; Joanna Sasal; Tanya Shulman; Manish M Sood; Andrew Steele; Paul Tam; Daniel Tascona; Davinder Wadehra; Ron Wald; Michael Walsh; Paul Watson; Walter Wodchis; Phillip Zager; Merrick Zwarenstein; Amit X Garg
Journal:  Can J Kidney Health Dis       Date:  2020-02-05

6.  Rationale and design of a multi-centre randomised controlled trial of individualised cooled dialysate to prevent left ventricular systolic dysfunction in haemodialysis patients.

Authors:  Aghogho Odudu; Mohamed Tarek Eldehni; Apostolos Fakis; Christopher William McIntyre
Journal:  BMC Nephrol       Date:  2012-06-21       Impact factor: 2.388

Review 7.  Clinical evidence on haemodiafiltration.

Authors:  Peter J Blankestijn; Muriel P Grooteman; Menso J Nube; Michiel L Bots
Journal:  Nephrol Dial Transplant       Date:  2018-10-01       Impact factor: 5.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.